Archive: 29/06/2017

US fraud trial underway for pharma bad boy Shkreli

The US securities fraud trial of Martin Shkreli, a former pharmaceutical executive who gained notoriety for jacking up the price of an HIV drug by 5,000 percent, got underway on Wednesday after being delayed over difficulties ...

page 7 from 8